Search Results - "FALOTICO, Robert"
-
1
Polymers for drug eluting stents
Published in Current pharmaceutical design (01-12-2010)“…Currently approved drug eluting stents (DES) consist of a metallic scaffold and an elutable drug dispersed in a polymer matrix that conformally surrounds the…”
Get more information
Journal Article -
2
Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration
Published in JACC. Cardiovascular interventions (28-12-2015)“…Abstract Objectives In the absence of effective clinical pharmacotherapy for prevention of reperfusion-mediated injury, this study re-evaluated the effects of…”
Get full text
Journal Article -
3
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model
Published in Circulation (New York, N.Y.) (04-09-2001)“…The purpose of this study was to determine the efficacy of stent-based delivery of sirolimus (SRL) alone or in combination with dexamethasone (DEX) to reduce…”
Get full text
Journal Article -
4
Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries
Published in European journal of pharmacology (07-11-2005)“…Sirolimus and paclitaxel eluted from stents inhibit cell proliferation and other cellular processes by dramatically different mechanisms. In this study, the…”
Get full text
Journal Article -
5
Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries
Published in Circulation (New York, N.Y.) (28-01-2003)“…The safety and efficacy of sirolimus-eluting stenting have been demonstrated, but the outcome of patients treated with this novel technology beyond the first…”
Get full text
Journal Article -
6
Microstructure and drug-release studies of sirolimus-containing poly(lactide-co-glycolide) films
Published in Journal of biomedical materials research. Part B, Applied biomaterials (01-04-2011)“…Sirolimus‐containing poly(lactide‐co‐glycolide) (PLGA) films were prepared by solution casting and removing the residual solvent, 1,4‐dioxane, by liquid and…”
Get full text
Journal Article -
7
Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent
Published in Coronary artery disease (01-05-2002)“…BACKGROUNDIn-stent restenosis is caused by neointimal hyperplasia. Sirolimus (rapamycin; Wyeth Research, Radnor, Pennsylvania, USA) inhibits vascular smooth…”
Get full text
Journal Article -
8
The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit
Published in Thrombosis and haemostasis (01-09-1998)“…It is unknown whether the addition of aspirin might increase both the efficacy and the potency of clopidogrel, a potent and selective ADP blocker. For that…”
Get more information
Journal Article -
9
Update on sirolimus drug-eluting stents
Published in Current pharmaceutical design (01-01-2004)“…Percutaneous transluminal coronary angioplasty (PTCA) has become the main method of coronary revascularization. However, despite technical advancement,…”
Get more information
Journal Article -
10
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
Published in The New England journal of medicine (06-06-2002)“…Despite advances in coronary angioplasty and stenting, restenosis remains an important problem that limits clinical success. This study compared a new coronary…”
Get full text
Journal Article -
11
Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model
Published in Cardiovascular research (01-09-2004)“…Stent-based delivery of sirolimus (SRL) has shown reduction in neointimal hyperplasia and restenosis. The purpose of this study was to evaluate the chronic…”
Get full text
Journal Article -
12
Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up
Published in Circulation (New York, N.Y.) (23-10-2001)“…We have previously reported a virtual absence of neointimal hyperplasia 4 months after implantation of sirolimus-eluting stents. The aim of the present…”
Get full text
Journal Article -
13
Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents
Published in Circulation (New York, N.Y.) (10-05-2005)“…Despite the proven superiority of sirolimus-eluting stents (SESs) compared with bare stents in the first year after implantation, long-term outcomes of…”
Get full text
Journal Article -
14
Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries : A quantitative coronary angiography and three-dimensional intravascular ultrasound study
Published in Circulation (New York, N.Y.) (16-01-2001)“…Restenosis remains an important limitation of interventional cardiology. Therefore, we aimed to determine the safety and efficacy of sirolimus (a cell-cycle…”
Get full text
Conference Proceeding Journal Article -
15
Sirolimus-eluting stent for the treatment of in-stent restenosis: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
Published in Circulation (New York, N.Y.) (07-01-2003)“…We have previously reported the safety and effectiveness of sirolimus-eluting stents for the treatment of de novo coronary lesions. The present investigation…”
Get full text
Journal Article -
16
Morphological and degradation studies of sirolimus-containing poly(lactide-co-glycolide) discs
Published in Journal of biomedical materials research. Part B, Applied biomaterials (01-04-2012)“…The effect of residual solvent and copolymer ratio on the in vitro degradation and drug release behavior of a bioabsorbable polymer/drug system was…”
Get full text
Journal Article -
17
A nonelutable low-molecular weight heparin stent coating for improved thromboresistance
Published in Journal of biomedical materials research. Part B, Applied biomaterials (01-07-2012)“…Low‐molecular weight heparin (LMWH) has been widely used as a systemic anticoagulant during percutaneous coronary intervention. In this study, LMWH was…”
Get full text
Journal Article -
18
Control of cilostazol release kinetics and direction from a stent using a reservoir-based design
Published in Journal of biomedical materials research. Part B, Applied biomaterials (01-04-2012)“…Sustained release formulations of a potent antithrombotic drug, cilostazol, in poly‐(lactic acid‐co‐glycolic acid) (PLGA) matrices were created for luminal…”
Get full text
Journal Article -
19
NEVO™: a new generation of sirolimus-eluting coronary stent
Published in EuroIntervention (15-12-2009)Get full text
Journal Article -
20
Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis
Published in Catheterization and cardiovascular interventions (01-05-2009)“…Objective: We compared local vessel healing and inflammatory responses associated with nonoverlapping sirolimus‐eluting stents (SES) and paclitaxel‐eluting…”
Get full text
Journal Article